Woodford Investment Management has shared the firm's insight into prospects for the top stocks in its £8.3bn Equity Income fund, including Legal & General and GlaxoSmithKline.
In a monthly blog for investors, fund manager Stephen Lamacraft highlighted the firm's outlook for the ten companies. The top holdings in the Woodford Equity Income fund are: Imperial Brands, GlaxoSmithKline, AstraZeneca, British American Tobacco, BT, Reynolds American, Roche, Legal & General, BAE Systems and Provident Financial. Commenting on Legal & General, Lamacraft said Woodford IM was "less concerned" about the group than others in the market, despite its exposure to corporate bonds. "We are less concerned - the company does indeed hold a substantial portfolio of corporate bo...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
